The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(2,4-Difluorophenyl)-4-aza-7,9-dideazaadenosine ID: ALA4636054
PubChem CID: 156014155
Max Phase: Preclinical
Molecular Formula: C17H16F2N4O4
Molecular Weight: 378.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccc(F)cc3F)c12
Standard InChI: InChI=1S/C17H16F2N4O4/c18-7-1-2-8(10(19)3-7)9-4-11(23-13(9)17(20)21-6-22-23)16-15(26)14(25)12(5-24)27-16/h1-4,6,12,14-16,24-26H,5H2,(H2,20,21,22)/t12-,14-,15-,16+/m1/s1
Standard InChI Key: XCVFQTFAGIWYAN-MIGQKNRLSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
31.7177 -28.1023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5390 -28.1023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7934 -27.3215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1304 -26.8352 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.4676 -27.3215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2365 -28.7670 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.0227 -28.7681 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6861 -27.0693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5751 -27.0700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0750 -27.6164 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.6564 -26.2868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8351 -26.2858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9079 -27.0685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2418 -27.5469 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.3260 -28.3615 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.0755 -28.6988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7417 -28.2112 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6543 -27.3983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3186 -26.9126 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.1381 -25.6267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9508 -25.7154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4323 -25.0561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1016 -24.3079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2845 -24.2230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8066 -24.8833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9938 -24.7988 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.5824 -23.6472 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
1 6 1 6
2 7 1 6
5 8 1 1
3 9 1 1
8 10 1 0
9 14 1 0
13 11 2 0
11 12 1 0
12 9 2 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
18 19 1 0
11 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
25 26 1 0
23 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.34Molecular Weight (Monoisotopic): 378.1140AlogP: 0.41#Rotatable Bonds: 3Polar Surface Area: 126.13Molecular Species: NEUTRALHBA: 8HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.71CX Basic pKa: 0.56CX LogP: 0.29CX LogD: 0.29Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.52Np Likeness Score: 0.01
References 1. Li Q, Groaz E, Persoons L, Daelemans D, Herdewijn P.. (2020) Synthesis and Antitumor Activity of C-7-Alkynylated and Arylated Pyrrolotriazine C-Ribonucleosides., 11 (8): [PMID:32832030 ] [10.1021/acsmedchemlett.0c00269 ]